US Patent

US12150956 — Trace element compositions, methods of making and use

Method of Use · Assigned to American Regent Inc · Expires 2041-07-01 · 15y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a stable injectable composition for parenteral nutrition that includes zinc, copper, selenium, or manganese.

USPTO Abstract

Injectable compositions that can be added to parenteral nutrition are provided. In particular, a stable injectable composition is provided which includes water, and at least one of about 800 μg to about 4,000 μg of zinc, about 40 μg to about 400 μg of copper, from about 4 μg to about 90 μg of selenium, or from about 1 μg to about 80 μg of manganese per 1 mL of the injectable composition. Methods of preparing and using of the stable injectable composition are also provided.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-3899 — cupric-sulfate
U-3899 — cupric-sulfate
U-3900 — cupric-sulfate

Patent Metadata

Patent number
US12150956
Jurisdiction
US
Classification
Method of Use
Expires
2041-07-01
Drug substance claim
No
Drug product claim
No
Assignee
American Regent Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.